Article

Predictable thinner flaps can be created with device

Author(s):

Tampere, Finland-The M2 microkeratome (Moria) received high marks from researchers who used the instrument to create thin flaps during LASIK.

Juhani Pietilä, MD, and Petri Mäkinen, MD, both refractive surgeons and investigators in the Department of Ophthalmology, Mehiläinen Hospital, Tampere, Finland, found that creating thin flaps with this microkeratome was safe and the results were reproducible. In addition, patient comfort was enhanced; the thin flaps recovered more quickly because of less flap swelling after the procedure.

"A thin flap theoretically decreases the risk of corneal ectasia, dry eye, and biomechanical effects," Dr. Pietilä said. "However, the risk of flap irregularities, buttonholes, and epithelial defects may increase when thinner flaps are created."

The M2 microkeratome has several characteristics that Dr. Pietilä said he finds very useful: the hinge can be positioned anywhere, there are different suction rings for different K values, the hinge length can be adjusted with different stop settings, and the heads are interchangeable, which allows the creation of thicker or thinner flaps.

The device has four heads to create different flap thicknesses. The metallic 130 head is used to create a flap 160 µm thick, the metallic 110 head is used for creation of a flap 140 µm thick, the plastic single-use 130 head creates a flap 160 µm thick, and a plastic single-use 110 head will produce a flap 120 µm thick.

In the study under discussion, a total of 300 eyes were treated with the following heads: 49 eyes with the metallic 130 head (M2 130), 114 eyes with the metallic 110 head (M2 110), 49 eyes with the plastic single-use 130 head (M2 SU 130), and 88 eyes with the plastic single-use 110 head (M2 SU 110).

Creating the flap

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
© 2025 MJH Life Sciences

All rights reserved.